Chronic gout: epidemiology, disease progression, treatment and disease burden

References

• National Center for Chronic Disease Prevention and Health Promotion. Arthritis. Available at: http://www.cdc.gov/arthritis/basics/gout.htm [Last accessed 17 May 2010]
   Google Scholar
• Kim K, Schumacher R, Hunsche E, et al. A literature review of the epidemiology and treatment of gout. Clin Ther 2003;25:1593-617
   PubMed Web of Science ®Google Scholar
• Lawrence RC, Felson DT, Helmick CG, et al. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum 2008;58:26-35
   PubMed Web of Science ®Google Scholar
• Kramer HM, Curhan G. The association between gout and nephrolithiasis: the National Health and Nutrition Examination Survey III, 1988–1994. Am J Kidney Dis 2002;40:37-42
   PubMed Web of Science ®Google Scholar
• Weaver A. Epidemiology of gout. Cleveland Clinic J Med 2008;Suppl. 5:S9-12
   Google Scholar
• Richette P, Bardin T. Gout. Lancet 2010;375:318-28
   PubMed Web of Science ®Google Scholar
• Choi H, Atkinson K, Karlson E, et al. Alcohol intake and risk of incident gout in men: a prospective study. Lancet 2004;363:1277-81
   PubMed Web of Science ®Google Scholar
• Choi H, Atkinson K, Karlson E, et al. Purine-rich foods, dairy and protein intake, and the risk of gout in men. N Engl J Med 2004;350:1093-103
   PubMed Web of Science ®Google Scholar
• Stamp L, Searle M, O’Donnell J, Chapman P. Gout in solid organ transplantation: a challenging clinical problem. Drugs 2005;65:2593-611
   PubMed Web of Science ®Google Scholar
• Becker MA, Schumacher HR, Benjamin KL, et al. Quality of life and disability in patients with treatment-failure gout. J Rheumatol 2009;36:865-8
   PubMed Web of Science ®Google Scholar
• Singh JA, Quality of life and quality of care for patients with gout. Current Rheumatology Reports 2009;11:154-60
   PubMedGoogle Scholar
• Brook RA, Kleinman NL, Patel PA, et al. The economic burden of gout on an employed population. Curr Med Res Opin 2006;22:1381-9
   PubMed Web of Science ®Google Scholar
• Wallace KL, Riedel AA, Joseph-Ridge N, et al. Increasing prevalence of gout and hyperuricemia over 10 years among older adults in a managed care population. J Rheumatol 2004;31:1582-7
   PubMed Web of Science ®Google Scholar
• Choi H, Atkinson K, Karlson E, et al. Obesity, weight change, hypertension, diuretic use, and risk of gout in men. The Health Professionals Follow-up Study. Arch Intern Med 2005;165:742-8
   PubMed Web of Science ®Google Scholar
• Campion EW, Glynn RJ, DeLabry LO. Asymptomatic hyperuricemia. Risks and consequences in the Normative Aging Study. Am J Med 1987;82:421-6
   PubMedGoogle Scholar
• Harrold LR, Andrade SE, Briesacher BA, et al. Adherence with urate-lowering therapies for the treatment of gout. Arthritis Res Ther 2009;11:R46
   PubMed Web of Science ®Google Scholar
• Choi H, Mount D, Reginato A. Pathogenesis of gout. Ann Intern Med 2005;143:499-516
   PubMed Web of Science ®Google Scholar
• Tykarski A. Evaluation of renal handling of uric acid in essential hypertension: hyperuricemia related to decreased urate secretion. Nephron 1991;59:364-8
   PubMed Web of Science ®Google Scholar
• National Kidney and Urologic Diseases National Clearinghouse (NKUDIC). Available at: http://kidney.niddk.nih.gov/ [Last accessed 17 May 2010]
   Google Scholar
• Abbott KC, Kimmel PL, Dharnidharka V, et al. New-onset gout after kidney transplantation: incidence, risk factors and implications. Transplantation 2005;80:1383-91
   PubMed Web of Science ®Google Scholar
• Novak S, Melkonian AK, Patel PA, et al. Metabolic syndrome-related conditions among people with and without gout: prevalence and resource use. Curr Med Res Opin 2007;23:623-30
   PubMed Web of Science ®Google Scholar
• Harris MD, Siegel LB, Alloway JA. Gout and hyperuricemia. Am Fam Physician 1999;59:925-34
   PubMed Web of Science ®Google Scholar
• Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 2006;8(Suppl. 1):S4
   PubMed Web of Science ®Google Scholar
• Watt I, Middlemiss H. The radiology of gout. Clin Radiol 1975;26:27-36
   PubMed Web of Science ®Google Scholar
• Bloch C, Hermann G, Yu TF. A radiologic reevaluation of gout: a study of 2,000 patients. AJR Am J Roentgenol 1980;134:781-7
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Clark B, McQueen F, et al. Validation of a radiographic damage index in chronic gout. Arthritis Rheum. 2007;57:1067-73
   PubMed Web of Science ®Google Scholar
• Schumacher HR, Wortmann RL. Monosodium urate crystal deposition arthropathy. Part 1: review of the stages and diagnosis of gout. Adv Stud Med 2005;5:133-8
   Google Scholar
• Teng GG, Nair R, Saag KG. Pathophysiology, clinical presentation and treatment of gout. Drugs 2006;66:1547-63
   PubMed Web of Science ®Google Scholar
• McDonald E, Marino C. Stopping progression to tophaceous gout. When and how to use urate-lowering therapy. Postgrad Med 1998;104:117-20,123-4,127
   PubMed Web of Science ®Google Scholar
• Li-Yu J, Clayburne G, Sieck M, et al. Treatment of chronic gout. Can we determine when urate stores are depleted enough to prevent attacks of gout? J Rheumatol 2001;28:577-80
   PubMed Web of Science ®Google Scholar
• Alvarez-Nemegyei J, Cen-Pisté JC, Medina-Escobedo M, et al. Factors associated with musculoskeletal disability and chronic renal failure in clinically diagnosed primary gout. J Rheumatol 2005;32:1923-7
   PubMed Web of Science ®Google Scholar
• Hall AP, Barry PE, Dawber TR, et al. Epidemiology of gout and hyperuricemia. A long-term population study. Am J Med 1967;42:27-37
   Google Scholar
• Wu E, Patel P, Yu A, et al. Frequency, risk, and cost of gout-related episodes among the elderly: does serum uric acid level matter? J Rheumatol 2009;36:1032-40
   PubMed Web of Science ®Google Scholar
• Fels E, Sundy JS. Refractory gout: what is it and what to do about it? Curr Opin Rheumatol 2008;20:198-202
   PubMed Web of Science ®Google Scholar
• Kerr LD. Inflammatory arthritis in the elderly. Mt Sinai J Med 2003;70:23-6
   PubMed Web of Science ®Google Scholar
• Jordan KM, Cameron JS, Snaith M, et al. British Society for Rheumatology and British Health Professionals in Rheumatology guidelines for the management of gout. Rheumatology 2007;46:1372-4
   PubMed Web of Science ®Google Scholar
• Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part II: Management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 2006;65:1312-24
   PubMed Web of Science ®Google Scholar
• Sarawate C, Patel P, Schumacher R, et al. Serum urate levels and gout flares – analysis from managed care data. J Clin Rheumatol 2006;12:61-5
   PubMed Web of Science ®Google Scholar
• Schlesinger N. Management of acute and chronic gouty arthritis. Present state-of-the-art. Drugs 2004;64:2399-416
   Google Scholar
• Sarawate C, Brewer K, Yang W, et al. Gout medication treatment patterns and adherence to standards of care from a managed care perspective. Mayo Clin Proc 2006;81:925-34
   PubMed Web of Science ®Google Scholar
• Mikuls R, Farrar JT, Bilker WB, et al. Suboptimal physician adherence to quality indicators for the management of gout and asymptomatic hyperuricaemia: results from the UK General Practice Research Database (GPRD). Rheumatology 2005;44:1038-42
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Carmona L, Pascual E, et al. The treatment of gout: results from the GEMA audit of clinical practice. Abstract 24, Arthritis Rheum 2008;60(Suppl.):S177
   Google Scholar
• O’Brien WR, Keenan RT, Crittenden DB, et al. Prevalence of co-morbidities and relative contraindications to standard therapies in a cohort of gout patients. Program and abstracts of the American College of Rheumatology (ACR) 2008 Annual Scientific Meeting; October 24–29, 2008; San Francisco, California. Abstract F92
   Google Scholar
• Becker MA, Schumacher HR, MacDonald PA, et al. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout. J Rheumatol 2009;36:1273-82
   PubMed Web of Science ®Google Scholar
• Perez-Ruiz F, Calabozo M, Pijoan JI, et al. Effect of urate-lowering therapy on the velocity of size reduction of tophi in chronic gout. Arthritis Rheum 2002;47:356-60
   PubMed Web of Science ®Google Scholar
• Puig JG, Casas EA, Ramos TH, et al. Plasma oxypurinol concentration in a patient with allopurinol hypersensitivity. J Rheumatol 1989;16:842-4
   PubMed Web of Science ®Google Scholar
• Gutiérrez-Macías A, Lizarralde-Palacios E, Martínez-Odriozola P, et al. Fatal allopurinol hypersensitivity syndrome after treatment of asymptomatic hyperuricaemia. BMJ 2005;331:623-4
   PubMed Web of Science ®Google Scholar
• Schumacher HR Jr, Becker MA, Lloyd E, et al. Febuxostat in the treatment of gout: 5-yr findings of the FOCUS efficacy and safety study. Rheumatology (Oxford) 2009;48:188-94
   PubMed Web of Science ®Google Scholar
• Strand V, Crawford B, Singh J, et al. Use of ‘spydergrams’ to present and interpret SF-36 health-related quality of life data across rheumatic diseases. Ann Rheum Dis 2009;68:1800-4
   PubMed Web of Science ®Google Scholar
• Edwards NL. The role of hyperuricemia in vascular disorders. Curr Opin Rheumatol 2009;21:132-7
   PubMed Web of Science ®Google Scholar
• Wu E, Patel P, Yu A, et al. Disease-related and all-cause health care costs of elderly patients with gout. J Manag Care Pharm 2008;14:164-75
   PubMed Web of Science ®Google Scholar
• Kleinman NL, Brook RA, Patel PA, et al. The impact of gout on work absence and productivity. Value Health 2007;10:231-7
   PubMed Web of Science ®Google Scholar
• Edwards NL, Blume S, Pan F, et al. Work productivity loss due to flares in treatment-failure gout (TFG). Arthritis Rheum 2008;58(Suppl.):S673
   Google Scholar
• World Health Organization (WHO). Revision of the International Classification of Diseases (ICD). Available at: http://www.who.int/classifications/icd/ICDRevision/en/index.html [Last accessed 17 May 2010]
   Google Scholar